Manufacturing, Biologic Drugs

Addressing Developmental Challenges of Gene Therapy Viral Vectors

October 16, 2022

Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.

Choosing the Right CDMO for CGT Programs

October 02, 2022

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

WuXi STA Opens a New Large-Scale Continuous Manufacturing Plant

July 27, 2022

WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.

Prefilled Syringes Show Strong Growth

July 03, 2022

Demand spurs innovations in syringes and syringe fill/finish operations.

MilliporeSigma to Supply Lotte Biologics with Biologics Manufacturing Capabilities in US

June 29, 2022

MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

June 10, 2022

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Seqirus Announces Completion of $156 Million Expansion of Vaccine Manufacturing Facility

June 10, 2022

The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

May 26, 2022

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

AGC Biologics Adds Viral Vector Suspension Technology at New US Campus

May 26, 2022

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

Demonstrating a Fully Continuous Bioprocess

May 16, 2022

Flexible and efficient methods are needed for biopharmaceutical manufacturing.